Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-17-022934

Director bought 25,000 shares at $2.59 ($64,750)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
CONWAY ROBERT E Director 2017-03-24 Purchase +25,000 $2.59 $64,750 25,000 D
Open-market purchases · 25,000 sh · avg $2.59 · $64,750
Loading xslF345X03/doc4.xml…